NCT05376527 2025-03-24Open Multi-cohort Study of the First Phase of Safety of a Drug Based on Double Recombinant Vaccinia Virus VV-GMCSF-Lact"Oncostar" LLCPhase 1 Completed34 enrolled
NCT00574977 2015-12-28Safety Study of Modified Vaccinia Virus to CancerUniversity of PittsburghPhase 1 Completed26 enrolled